A recent case report about a man who received an mRNA-based COVID-19 vaccine suggests that taking the vaccine “may trigger immune-mediated hepatitis,” researchers wrote.
The case report does not indicate how common such a case would be, although researchers said that such a scenario is recognized as a “rare adverse event not identified in early trials.”
